Reference cards
Bedside summaries with the numbers that matter first. Verify every dose and pathway against your local protocol.
- Emergency
Febrile neutropenia
Time-critical. Empiric broad-spectrum antibiotics within 60 minutes of the first recorded fever.
Awaiting clinical review · Pending oncology pharmacist sign-off - Emergency
Tumour lysis syndrome
Highest risk in bulky ALL, Burkitt and high-WCC presentations during the first 72 h of therapy.
Awaiting clinical review - Protocol
ALL treatment phases
Phase-by-phase map of a typical B-ALL regimen with the monitoring focus for each block.
Draft — not reviewed - Procedure
Central line care and complications
Access, occlusion and suspected line-infection decision points.
Awaiting clinical review - Supportive care
Chemotherapy-induced nausea and vomiting
Match prophylaxis to the emetogenic tier before the first dose, not after the first vomit.
Awaiting clinical review - Protocol
Dosing safety checks
BSA vs weight banding, organ-function adjustment and the double-check chain.
Draft — not reviewed